American Journal of Medical Case Reports. 2014, 2(1), 19-21
DOI: 10.12691/AJMCR-2-1-6
A Rare Case of Chronic Myeloid Leukemia At a Patient with Achondroplasia
Ilknur Nizam1, , Mehmet Ali Erkurt1, Ilhami Berber1, Emin Kaya1 and Irfan Kuku1
1Department of Hematology, Faculty of Medicine, Inonu University, Malatya, Turkey
Pub. Date: January 17, 2014
Cite this paper
Ilknur Nizam, Mehmet Ali Erkurt, Ilhami Berber, Emin Kaya and Irfan Kuku. A Rare Case of Chronic Myeloid Leukemia At a Patient with Achondroplasia.
American Journal of Medical Case Reports. 2014; 2(1):19-21. doi: 10.12691/AJMCR-2-1-6
Abstract
The coincidence of chronic myeloid leukemia (CML) and achondroplastic dwarfism is very rare. A 40-year old man with achondroplastic dwarfism was diagnosed with chronic myeloid leukemia in blastic phase with a Sokal index of 1.34. Standart dose imatinib treatment was immediately started after the diagnosis.
Keywords
chronic myeloid leukemia, achondroplasia, CML, achondroplastic dwarfism
Copyright
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
http://creativecommons.org/licenses/by/4.0/
References
[1] | Geromin A, Sperotto A, Fanin R, Damiani D, Michieli M, Baccarani M. Bone marrow transplantation in a patient with chronic myeloid leukemia and achondroplasia. Haematologica. 1997 Nov-Dec; 82 (6): 703-4. |
|
[2] | Karkuzhali P, Shanthi V, Usha. T A case of chronic myeloid leukaemia presenting as megakaryocytic blast crisis (AML M7) Ecancermedicalscience. 2013; 7: 375. |
|
[3] | Van Etten RA. c-Abl regulation: a tail of two lipids. Curr Biol 2003; 13: R608. |
|
[4] | Jabbour E, Kantarjian H: Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management. Am J Hematol 87 (11): 1037-45, 2012. |
|
[5] | Stoll C, Feingold J. Do Parents and Grandparents of Patients With Achondroplasia Have a Higher Cancer Risk? American Journal of Medical Genetics 130A: 165-168 (2004). |
|
[6] | Kantarjian HM, Hochhaus A, Saglio G, et al.: Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial. Lancet Oncol 12 (9): 841-51, 2011. |
|